News
Chronic respiratory illnesses affect millions. Learn how PCPs can effectively manage asthma, COPD, and allergies through ...
1h
Zacks Investment Research on MSNVerve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From LillyVerve Therapeutics VERV signed a definitive agreement with pharma bigwig Eli Lilly LLY. Per the terms, the pharma giant will ...
The specialty drug pipeline is robust with several new medications anticipated to gain approval in the coming years. Healthcare leaders need to be poised to have a deep understanding of the clinical ...
With Viatris taking home the biggest prize at this year’s Cannes Pharma Lions award and Biogen winning Gold, pharma is making ...
15h
Stars Insider on MSNFDA approved: New medications and vaccinesAlzheimer's patients have new hope with Kisunla and Zunveyl, which target the disease in unprecedented ways, while Dupixent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results